Related Experiment Video
Updated: Jun 23, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus
Hainan Chen1, Xueying Gu, I-hsin Su
1Department of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA.
Abstract:
Proliferation of pancreatic islet beta cells is an important mechanism for self-renewal and for adaptive islet expansion. Increased expression of the Ink4a/Arf locus, which encodes the cyclin-dependent kinase inhibitor p16(INK4a) and tumor suppressor p19(Arf), limits beta-cell regeneration in aging mice, but the basis of beta-cell Ink4a/Arf regulation is poorly understood. Here we show that Enhancer of zeste homolog 2 (Ezh2), a histone methyltransferase and component of a Polycomb group (PcG) protein complex, represses Ink4a/Arf in islet beta cells. Ezh2 levels decline in aging islet beta cells, and this attrition coincides with reduced histone H3 trimethylation at Ink4a/Arf, and increased levels of p16(INK4a) and p19(Arf). Conditional deletion of beta-cell Ezh2 in juvenile mice also reduced H3 trimethylation at the Ink4a/Arf locus, leading to precocious increases of p16(INK4a) and p19(Arf). These mutant mice had reduced beta-cell proliferation and mass, hypoinsulinemia, and mild diabetes, phenotypes rescued by germline deletion of Ink4a/Arf. beta-Cell destruction with streptozotocin in controls led to increased Ezh2 expression that accompanied adaptive beta-cell proliferation and re-establishment of beta-cell mass; in contrast, mutant mice treated similarly failed to regenerate beta cells, resulting in lethal diabetes. Our discovery of Ezh2-dependent beta-cell proliferation revealed unique epigenetic mechanisms underlying normal beta-cell expansion and beta-cell regenerative failure in diabetes pathogenesis.
Insights
Enhancer of zeste homolog 2 (Ezh2) represses Ink4a/Arf in pancreatic islet beta cells. Declining Ezh2 in aging cells impairs beta-cell regeneration and contributes to diabetes pathogenesis.
Area of Science:
- Endocrinology
- Epigenetics
- Cell Biology
Background:
- Pancreatic islet beta cell proliferation is crucial for self-renewal and adaptive expansion.
- The Ink4a/Arf locus, encoding p16(INK4a) and p19(Arf), limits beta-cell regeneration in aging mice.
- Regulation of beta-cell Ink4a/Arf is poorly understood.
Purpose of the Study:
- To investigate the role of Enhancer of zeste homolog 2 (Ezh2) in regulating Ink4a/Arf expression in pancreatic islet beta cells.
- To elucidate the mechanisms underlying beta-cell regenerative failure in aging and diabetes.
Main Methods:
- Utilized conditional Ezh2 deletion in beta cells of juvenile mice.
- Assessed histone H3 trimethylation at the Ink4a/Arf locus.
- Quantified levels of p16(INK4a), p19(Arf), beta-cell proliferation, and mass.
- Induced beta-cell destruction using streptozotocin in control and mutant mice.
Main Results:
- Ezh2 represses Ink4a/Arf in islet beta cells.
- Ezh2 levels decline in aging beta cells, correlating with reduced histone methylation and increased p16(INK4a)/p19(Arf).
- Conditional beta-cell Ezh2 deletion caused precocious Ink4a/Arf induction, reduced beta-cell mass, hypoinsulinemia, and mild diabetes, phenotypes rescued by Ink4a/Arf deletion.
- In response to injury, control mice showed increased Ezh2 and beta-cell regeneration, while mutant mice failed to regenerate, leading to lethal diabetes.
Conclusions:
- Ezh2 is a key epigenetic regulator of beta-cell proliferation and regeneration.
- Ezh2-dependent regulation of Ink4a/Arf is critical for maintaining beta-cell mass and function.
- Dysregulation of Ezh2 contributes to age-related beta-cell regenerative failure and diabetes pathogenesis.
Related Concept Videos
Cell Specific Gene Expression
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology
Insulin Secretory Vesicles
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
